Ketogenesis restrains aging-induced exacerbation of COVID in a mouse model
Abstract
Increasing age is the strongest predictor of risk of COVID-19 severity. Unregulated cytokine storm together with impaired immunometabolic response leads to highest mortality in elderly infected with SARS-CoV-2. To investigate how aging compromises defense against COVID-19, we developed a model of natural murine beta coronavirus (mCoV) infection with mouse hepatitis virus strain MHV-A59 (mCoV-A59) that recapitulated majority of clinical hallmarks of COVID-19. Aged mCoV-A59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue and hypothalamus, including neutrophilia and loss of γδ T cells in lungs. Ketogenic diet increases beta-hydroxybutyrate, expands tissue protective γδ T cells, deactivates the inflammasome and decreases pathogenic monocytes in lungs of infected aged mice. These data underscore the value of mCoV-A59 model to test mechanism and establishes harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against COVID-19 in the elderly.
Highlights
-
<label>-</label>
Natural MHV-A59 mouse coronavirus infection mimics COVID-19 in elderly.
-
<label>-</label>
Aged infected mice have systemic inflammation and inflammasome activation
-
<label>-</label>
Murine beta coronavirus (mCoV) infection results in loss of pulmonary γδ T cells.
-
<label>-</label>
Ketones protect aged mice from infection by reducing inflammation.
eTOC Blurb
Elderly have the greatest risk of death from COVID-19. Here, Ryu et al report an aging mouse model of coronavirus infection that recapitulates clinical hallmarks of COVID-19 seen in elderly. The increased severity of infection in aged animals involved increased inflammasome activation and loss of γδ T cells that was corrected by ketogenic diet.
Related articles
Related articles are currently not available for this article.